Collaboration in research protocol design: A case study exploring knowledge creation for the pharmaceutical industry and prescribing physicians

Journal of Medical Marketing

Volumn 9, Issue 3, 2009, Pages 213-220

  Richards, Deborah ^a   Dalton, Brad ^b,c  

^a Gilead Sciences   (Australia)

^b medScript   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69749095734     PISSN: 17457904     EISSN: 17457912     Source Type: Journal    
DOI: 10.1057/jmm.2009.20     Document Type: Article

References (15)

1. Yamada, T. (2005) Academia-industry collaboration: A dynamic partnership on behalf of patients. Journal of Clinical Investigations 115: 2944-2947.
2. Glass, H. (2003) Physician participation in market support clinical studies and subsequent prescribing behavior. Journal of Pharmaceutical Marketing and Management 15(4): 3-16.
3. Pharmaceuticals Industry Council. (2009) R&D taskforce 2009 forum: The future in context, http://www.pharmacouncil.com.au/resources.php, accessed 7 April 2009.
4. Malek, J. and Breggar, M. (2001) The new R&D paradigm. Pharmaceutical Executive 21(2): 78-86.
5. Drucker, RE (2002) Managing in the Next Society. Oxford: Butterworth-Heinemann.
6. Murtaugh, T., Furey, D. and Steen, R. (2002) What marketers want. Pharmaceutical Executive 12: 90-96.
7. Checkland, P. and Holwell, S. (1998) Action research: Its nature and validity. Systemic Practice and Action Research 11(1): 9-21.
8. Duvall, D. (2006) Conflict of interest or ideological divide: The need for ongoing collaboration between physicians and industry. Current Medical Research and Opinion 22: 1807-1812.
9. Medicines Australia. (2007) Code of Conduct, 15th edn. Canberra. Medicines Australia.
10. Aiken, P. and Katona, C. (2006) Working with the drug industry - is your reputation at risk? BMJ Careers 330(7488): 73-75.
11. Bodenheimer, T. (2000) Uneasy alliance: Clinical investigators and the pharmaceutical industry. The New England Journal of Medicine 342: 1539-1544.
12. Nuyens, Y. and Lansang, M.A. (2006) Knowledge translation: Linking the past to the future. Bulletin of the World Health Organization 84(8): 590.
13. Cacciotti, J. and Shew, B. (2006) Pharma's next top model: Slimmer business models. Pharmaceutical Executive 26(3): 82-86.
14. Buchel, B. (2007) Knowledge creation and transfer; from team to the whole organization. In: K. Ichijo and I. Nonaka (eds.) Knowledge Creation and Management New Challenges for Managers. New York: Oxford University Press.
15. Allee, V. (2003) The Future of Knowledge: Increasing Prosperity Through the Value of Networks. Burlington, VT: Elsevier.